Inhibikase Therapeutics
IKT
IKT
25 hedge funds and large institutions have $6.85M invested in Inhibikase Therapeutics in 2021 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 5 increasing their positions, 3 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
12% less capital invested
Capital invested by funds: $7.78M → $6.85M (-$934K)
Holders
25
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$296K | |
| 2 | +$97.7K | |
| 3 | +$84K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$78.1K |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$19.1K |
Top Sellers
| 1 | -$192K | |
| 2 | -$148K | |
| 3 | -$53K | |
| 4 |
Envestnet Asset Management
Chicago,
Illinois
|
-$21K |
| 5 |
WAM
Warberg Asset Management
Winnetka,
Illinois
|
-$19.5K |